Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-075868

Options or other derivatives

  • Director acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MILLER MICHAEL PATRICK Director 2023-06-26 Grant or award · Stock Option (Right to Buy) +17,000 17,000 D
Loading xslF345X04/tm2319786-2_4seq1.xml…